Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Phase 2 clinical trials published in 2023 demonstrated unprecedented weight loss efficacy, with participants achieving up to 24.2% body weight reduction over 48 weeks results approaching those typically observed only with bariatric surgery[1]
Both brands combine telehealth prescribing with behavior support, but they are built for different types of patients
STEP 1, SURMOUNT-1, and the Jastreboff Phase 2 enrolled different populations
A 2026 meta-analysis in The Lancet confirmed: 12+ hour fasts daily slash liver disease risk by 25%
Any combination use should be guided by available research data
US$ 29.15
US$ 21.36
US$ 29.55
US$ 29.41
